Data Description: The Volume of Distribution at Steady State (VDss) quantifies how a drug distributes between the plasma and the tissues. A high VDss indicates extensive tissue distribution, while a low VDss suggests confinement primarily within the blood vessels.

Data Description: Plasma clearance (CL_plasma) is a critical pharmacokinetic parameter that determines the body's ability to eliminate a drug. It reflects the drug elimination rate, adjusted for the plasma concentration. This parameter is key to understanding how much of the drug remains in circulation and helps calculate the dosage needed to maintain a steady plasma concentration over time.

Data Description: The fraction unbound in plasma (Fu) refers to the portion of a drug that is not bound to plasma proteins and is free to exert its pharmacological effect. Most drugs in plasma exist in equilibrium between being unbound or bound to serum proteins. The efficacy of a drug can be influenced by how much of it is bound, as a higher binding fraction reduces the drug's ability to diffuse across cell membranes or interact with its target.

Data Description: Mean Retention Time (MRT) represents the average time a drug molecule remains in the body following rapid administration. MRT is a pharmacokinetic parameter that describes the process of drug elimination. It is calculated as MRT = AUMC / AUC, where AUMC is the area under the first-order moment of the plasma concentration-time curve. For drugs with a one-compartment distribution model, MRT is equivalent to the reciprocal of the elimination rate constant.

Data Description: Half-life (T_1/2) is the time required for the plasma concentration of a drug to decrease by half. It reflects the rate of drug elimination and is a key pharmacokinetic parameter describing how quickly a drug is cleared from the body.